Concentrix is trading at $22.84, down -8.22%, after September 29 results showed Q3 revenue below expectations.

  • Q3 revenue was $2.45 billion, down 1.2% year over year, despite $2.92 non-GAAP EPS.
  • Investors are weighing Q4 guidance for a 3%–5% constant-currency revenue decline and a $1.05 billion non-cash goodwill impairment.
  • FY2026 non-GAAP EPS outlook is $10.97–$11.09, but stronger profit guidance has not offset near-term revenue concerns.